Radius Health Receives $43,000,000 New Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=c7f2cac0-3c5b-4e86-881e-d056e554fae3&Preview=1 - Date
4/26/2013 - Company Name
Radius Health - Mailing Address
201 Broadway 6th Floor Cambridge, MA 02139 - Company Description
Radius is a leading company in the discovery and development of a new generation of drug therapies for osteoporosis and women’s health. - Website
http://www.radiuspharm.com - Transaction Type
Venture Equity - Transaction Amount
$43,000,000 - Transaction Round
Undisclosed - Proceeds Purposes
Radius Health plans to use the funding to support the continued advancement of the company’s clinical development programs for its lead asset, BA058, a novel anabolic, bone-building compound for the treatment of patients with osteoporosis at high risk of fracture. - M&A Terms
- Venture Investor
F2 Biosciences - Venture Investor
Biotech Growth N.V. - Venture Investor
MPM Capital - Venture Investor
Brookside Capital - Venture Investor
BB Biotech Ventures
